Prostate Cancer Research progress at Cabrini

This Prostate Cancer Awareness Month (September), we say a huge congratulations to the Cabrini Cancer Institute and Monash University’s Biomedicine Discovery Institute (BDI) on their ground breaking research driving better outcomes for men with prostate cancer.

Led by Mark Frydenberg AM MBBS FRACS FAICD and Professor Gail Risbridger AM, this extraordinary clinician–scientist collaboration is changing lives.

From growing tumours in the lab to developing personalised treatments and launching world-class drug development programs, their work is placing Australia at the forefront of global prostate cancer innovation.

Prostate cancer is the most commonly diagnosed cancer among Australian men — and thanks to this team’s efforts, there's renewed hope.

This life-saving progress is only possible because of our generous supporters, whose vision and commitment fuel every discovery.

Together, we empower breakthroughs. We deliver hope. We save lives.

‍